Development of a Mobile Application of Breast Cancer e-Support Program for Women with Breast Cancer undergoing Chemotherapy
Development of a Mobile Application of Breast Cancer e-Support Program for Women with Breast Cancer undergoing Chemotherapy
复制标题
为接受化疗的乳腺癌女性开发乳腺癌电子支持计划的移动应用程序
DOI：
10.3233/thc-161292
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Sally Wai-Chi CHAN
中科院分区：
文献类型：
--
作者：
Zhu JM.;Lyn Ebert;Zhimin Xue;Qu SHEN;Sally Wai-Chi CHAN
背景：乳腺癌患者在接受化疗后会出现各种生理和心理社会症状，这些症状对女性的生活质量和心理健康都有负面影响。尽管移动健康技术提供了创新和容易获得的选择来提供心理社会支持，但基于手机的干预措施对中国的这些女性仍然有限。目的：开发一种新的移动应用程序，为接受化疗的乳腺癌妇女提供信息以及社会和情感支持，以提高她们的自我效能感和社会支持，从而改进症状管理策略。方法：在已有理论框架的基础上，结合班杜拉的自我效能感理论和社会交换理论，设计了一个新的移动应用程序--乳腺癌e-Support Program(BCS)，并通过专家组和乳腺癌妇女对其内容和功能进行了验证。结果：BCS App程序有四个模块：1)学习论坛；2)讨论论坛；3)专家问答论坛；4)个人故事论坛。BCS计划可以应用于Android手机和iPhone，以接触到更多的女性。结论：这是中国为乳腺癌化疗妇女研制的首例此类药物。一项随机对照试验正在进行，以检验BCS方案的有效性。
BACKGROUND: Women with breast cancer undergoing chemotherapy experience a variety of physical and psychosocial symptoms, which have negative effect on women’s quality of life and psychological well-being. Although M-health technologies provides innovative and easily accessible option to provide psychosocial support, mobile phone based interventions remain limited for these women in China. .OBJECTIVE: To develop a new mobile application to offer information as well as social and emotional support to women with breast cancer undergoing chemotherapy to promote their self-efficacy and social support, thus improving symptom management strategies. .METHODS: Basing on previous theoretical framework which incorporated Bandura’s self-efficacy theory and the social exchange theory, a new mobile application, called Breast Cancer e-Support Program (BCS) was designed, with the content and functionality being validated by the expert panel and women with breast cancer. .RESULTS: BCS App program has four modules: 1) Learning forum; 2) Discussion forum; 3) Ask-the-Expert forum; and 4) Personal Stories forum. BCS program can be applied on both android mobile phones and iPhones to reach more women. .CONCLUSIONS: This is the first of its kind developed in China for women with breast cancer undergoing chemotherapy. A randomized controlled trial is undertaking to test the effectiveness of BCS program..